Evaluation of DPC Immulite 2000® toxoplasma quantitative IgG/IgM kits for automated toxoplasmosis serology with Immulite 2000®

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 5, 2009, Pages 336-340

  Robert Gangneux, Florence ^a,b   Bourhis, Chantal ^c   Chevrier, Sylviane ^a   Gangneux, Jean Pierre ^a,b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

Antibody; ELISA; Serological diagnosis; TORCH screening; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; AUTOANALYSIS; CONGENITAL TOXOPLASMOSIS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; NEWBORN SCREENING; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROLOGY; TOXOPLASMA; TOXOPLASMOSIS;

ANTIBODIES, PROTOZOAN; AUTOMATION; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TITRIMETRY; TOXOPLASMA; TOXOPLASMOSIS;

TOXOPLASMA;

EID: 70349534376     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20338     Document Type: Article

References (20)

1. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994;330:1858-1863.
2. Montoya JG, Liesenfeld O, Kinney S, Press C, Remington JS. VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J Clin Microbiol 2002;40:2504-2508. (Pubitemid 34747355)
3. Roux-Buisson N, Fricker-Hidalgo H, Foussadier A, et al.. Comparative analysis of the VIDAS Toxo IgG IV assay in the detection of antibodies to Toxoplasma gondii. Diagn Microbiol Infect Dis 2005;53:79-81.
4. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy: A multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999;1802:410-415. (Pubitemid 29093877)
5. Fricker-Hidalgo H, Pelloux H, Racinet C, Bost M, Goullier-Fleuret A, Ambroise-Thomas P. Congenital toxoplasmosis: Specific IgM in fetal blood, cord blood and in the newborn. Ann Biol Clin 1996;54:165-168. (Pubitemid 126751965)
6. Hezard N, Marx-Chemla C, Foudrinier F, et al. Prenatal diagnosis of congenital toxoplasmosis in 261 pregnancies. Prenat Diagn 1997;17:1047-1054. (Pubitemid 27477864)
7. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F. Prenatal diagnosis of congenital toxoplasmosis with a polymerase chain reaction test on amniotic fluid. N Engl J Med 1994;331:695-699. (Pubitemid 24275741)
8. Pinon JM, Chemla C, Villena I, et al. Early neonatal diagnosis of congenital toxoplasmosis: Value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol 1996;34:579-583. (Pubitemid 26065779)
9. Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaefer C, Dupouy-Camet J. Congenital toxoplasmosis: Value of prenatal diagnosis and early postnatal diagnosis. A retrospective study of 110 cases. J Clin Microbiol 1999;37:2893-2898. (Pubitemid 29391906)
10. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H. Results of 20 years follow-up of congenital toxoplasmosis. Lancet 1986;i:254-256.
11. McAuley J, Boyer KM, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial. Clin Infect Dis 1994;18:38-72. (Pubitemid 24025917)
12. Villena I, Aubert D, Leroux B, et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: Follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 1998;30:295-300.
13. Owen WE, Martins TB, Litwin CM, Roberts WL. Performance characteristics of six Immulite 2000 TORCH assays. Am J Clin Pathol 2006;126:900-905.
14. Villena I, Bory JP, Chemla C, Hornoy P, Pinon JM. Congenital toxoplasmosis: Necessity of clinical and ultrasound follow-up despite negative amniocentesis. Prenat Diagn 2003;23:1098-1099. (Pubitemid 38084156)
15. Kaul R, Chen P, Binder SR. Detection of immunoglobulin M antibodies specific for Toxoplasma gondii with increased selectivity for recently acquired infections. J Clin Microbiol 2004;42:5705-5709. (Pubitemid 39664356)
16. Roberts F, Mc Leod R. Pathogenesis of toxoplasmic retinochor- PIditis. Parasitol Today 1999;15:51-58.
17. Fricker-Hidalgo H, Pelloux H, Racinet C, et al. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo, and in vitro cultures. Placenta 1998;19:545-549. (Pubitemid 28430009)
18. Robert-Gangneux F, Commere V, Tourte-Schaefer C, Dupouy-Camet J. Performance of a Western blot assay to compare mother and newborn anti-Toxoplasma antibodies for the early neonatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 1999;18:648-654. (Pubitemid 29531241)
19. Tissot Dupont D, Fricker-Hidalgo H, Brenier-Pinchart MP, Bost-Bru C, Ambroise-Thomas P, Pelloux H. Usefulness of Western blot in serological follow-up of newborns suspected of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 2003;22:122-125. (Pubitemid 36349977)
20. Pinon JM, Dumon H, Chemla C, et al. Strategy for diagnosis of congenital toxoplasmosis: Evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 2001;39:2267-2271. (Pubitemid 32531492)